Risk of Visual Impairment in Children with Congenital Toxoplasmic Retinochoroiditis

American Journal of Ophthalmology

Volumn 144, Issue 5, 2007, Pages

  Tan, Hooi Kuan ^a   Schmidt, Dorthe ^b   Stanford, Miles ^c   Teär Fahnehjelm, Kristina ^d   Ferret, Nicole ^e   Salt, Alison ^a   Gilbert, Ruth ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b STATENS SERUM INSTITUT   (Denmark)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHORIORETINITIS; CLINICAL EXAMINATION; COHORT ANALYSIS; CONGENITAL TOXOPLASMOSIS; EYE EXAMINATION; FEMALE; FOLLOW UP; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; NEWBORN SCREENING; OPHTHALMOSCOPY; OUTCOME ASSESSMENT; PREDICTION; PRENATAL DIAGNOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELIABILITY; RISK ASSESSMENT; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 35548939491     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2007.07.013     Document Type: Article

References (20)

1. Gras L., Wallon M., Pollak A., et al. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centers. Acta Paediatr 94 (2005) 1721-1731
2. Binquet C., Wallon M., Quantin C., et al. Prognostic factors for the long-term development of ocular lesions in 327 children with congenital toxoplasmosis. Epidemiol Infect 131 (2003) 1157-1168
3. Wallon M., Kodjikian L., Binquet C., et al. Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics 113 (2004) 1567-1572
4. Gilbert R., and Dezateux C. Newborn screening for congenital toxoplasmosis: feasible, but benefits are not established. Arch Dis Child 91 (2006) 629-631
5. Gomez-Marin J.E., and delaTorre A. Positive benefit of postnatal treatment in congenital toxoplasmosis. Arch Dis Child 92 (2007) 88-89
6. Freeman K., Salt A., Prusa A., et al. Association between congenital toxoplasmosis and parent-reported developmental outcomes, concerns and impairments, in 3-year-old children. BMC Pediatr 5 (2005) 23
7. Mets M.B., Holfels E., Boyer K.M., et al. Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 122 (1996) 309-324
8. Brezin A.P., Thulliez P., Couvreur J., Nobre R., McLeod R., and Mets M.B. Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis. Am J Ophthalmol 135 (2003) 779-784
9. Gilbert R., and Gras L. European Multicentre Study on Congenital Toxoplasmosis. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG 110 (2003) 112-120
10. Lebech M., Andersen O., Christensen N.C., et al. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Lancet 353 (1999) 1834-1837
11. Rydberg A., and Ericson B. Assessing visual function in children younger than 1 1/2 years with normal and subnormal vision: evaluation of methods. J Pediatr Ophthalmol Strabismus 35 (1998) 312-319
12. Rahi J., Logan S., Timms C., Russell-Eggitt I., and Taylor D. Risk, causes, and outcomes of visual impairment after loss of vision in the non-amblyopic eye: a population-based study. Lancet 360 (2002) 597-602
13. Dutton G.N., and Jacobson L.K. Cerebral visual impairment in children. Semin Neonatol 6 (2001) 477-485
14. Scherrer J., Iliev M.E., Halberstadt M., Kodjikian L., and Garweg J.G. Visual function in human ocular toxoplasmosis. Br J Ophthalmol 91 (2007) 233-236
15. Stanford M.R., Tomlin E.A., Comyn O., Holland K., and Pavesio C. The visual field in toxoplasmic retinochoroiditis. Br J Ophthalmol 89 (2005) 812-814
16. Kodjikian L., Wallon M., Fleury J., et al. Ocular manifestations in congenital toxoplasmosis. Graefes Arch Clin Exp Ophthalmol 244 (2006) 14-21
17. Thiebaut R., Leproust S., Chene G., Gilbert R.E., and The SYROCOT Study Group. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet 369 (2007) 115-122
18. Gras L., Gilbert R.E., Ades A.E., and Dunn D.T. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis. Int J Epidemiol 30 (2001) 1309-1330
19. Williams C., Harrad R.A., Harvey I., Sparrow J.M., and ALSPAC Study Team. Screening for amblyopia in preschool children: results of a population-based, randomized controlled trial. ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Ophthalmic Epidemiol 8 (2001) 279-295
20. Holland G.N. Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management. Am J Ophthalmol 137 (2004) 1-17